Skip to content
Ships from Provo, Utah · We ship to CanadaAll Prices are in US DollarsFor Research Use Only. Not for Human Consumption.

Topical GHK–Copper in Ischemic Rat Wounds: The Vehicle Comparison Matters

A topical formulation can differ from no treatment for reasons beyond its active ingredient. Including a vehicle group helps make the comparison more informative. Primary study

What was reported

The experiment involved 24 rats with wounds created in ischemic skin flaps. It compared a GHK–copper gel, its vehicle, and no treatment over 13 days. Wound-area differences favored the peptide formulation against untreated controls on several days, but significant differences against vehicle were reported only on selected days. Tissue inflammatory and remodeling markers were also measured. Primary report

Our appraisal: do not erase the middle group

The untreated comparison asks about the whole treatment package. The vehicle comparison more closely addresses the contribution of adding the active material to that package. These questions overlap but are not identical, and their results should not be blended into a single claim of superiority at every time point.

Daily wound measurements create repeated observations from the same experimental units. A careful analysis should account for that dependence and for the number of time-point comparisons. A reader should not assume that each day's measurement represents a new independent experiment.

Wound area is also not the same as complete restoration of tissue quality. Contraction, epithelial coverage, strength, infection, and longer-term remodeling can follow different patterns. A smaller area at a selected visit does not establish every one of those outcomes.

The ischemic model deliberately changes the wound environment. It can help investigate impaired healing, but it does not reproduce every chronic wound or establish effectiveness in people.

The study supports a formulation-specific animal signal, with a more limited vehicle comparison than a simple untreated-control headline might suggest. It does not validate another carrier, an injectable product, or human wound self-treatment.

Frequently asked questions

Were three groups included?

Yes.

Was the vehicle tested separately?

Yes.

Were vehicle differences significant on every day?

No.

Was this a human wound trial?

No.

Is wound-area reduction the same as complete tissue restoration?

No.

Are repeated daily measurements independent animals?

No.

Does this validate a different formulation?

No.

Information you can check.

Lab reports, store policies, and support — all in one place.

Card options
Visa Mastercard
Available payment options are shown at checkout.
HTTPS connection

For research use only.
Not for human consumption.